France Cardiovascular Devices Market Insight
Published: 23 July 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The growth rate of the cardiovascular devices market in France is expected to grow at a rate of 6.45% owing to increasing applications of minimally invasive cardiac procedures, higher installations of advanced structural heart devices, growing usage of AI-enabled electrophysiology systems, and expanding geriatric healthcare services.
France Cardiovascular Devices Market Insights Forecasts to 2035
- The France Cardiovascular Devices Market Size Was Estimated USD 2,340.5 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.45% from 2025 to 2035
- The France Cardiovascular Devices Market Size is Expected to rise around USD 4,374.8 Million by 2035
Notable Insights for the France Cardiovascular Devices Market
- Based on the Segmentation by Product Type, it can be observed that the Structural Heart Devices & Transcatheter Implants segment is taking lead in France Cardiovascular Devices Market in 2025, holding almost 52% of the total market share due to growing use of transcatheter aortic valve replacement systems in interventional cardiology, cardiac surgery centers, and specialty hospital networks.
- Based on the Segmentation by Application, it can be seen that Hospitals, Specialty Cardiac Centers & Ambulatory Surgical Units segment held a market share of about 64% in France Cardiovascular Devices Market in 2025, mainly driven by growing demands for minimally invasive vascular procedures, advanced cardiac rhythm management, and electrophysiology interventions.
- The global revenue of Medtronic plc in fiscal year 2025 stood at nearly $32.4 billion backed by growing demands for cardiovascular implants, cardiac rhythm monitoring devices, and transcatheter structural heart platforms.
- Increasing investments in AI-based cardiac diagnostics, smart pacemakers, and digital remote patient monitoring networks will fuel the growth of the market in coming years, as advanced cardiovascular device technology enhances procedural accuracy up to 45% and minimizes surgical complication risks up to 28%.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
Intelligent Market Research Based on AI for Healthcare & Cardiovascular Devices
Decisions Advisors offers intelligent market research which includes advanced analysis of cardiovascular device technologies, structural heart implants, AI-driven electrophysiology platforms, and interventional cardiology solutions. Our research identifies potential areas of business development, technology adoption rates, competitive position analysis, and important strategic changes in France Cardiovascular Devices Market.
Highly Effective Research Approaches with Accurate Forecast Analysis
The research process uses advanced methodologies such as primary research interview approaches, industry research, tracking the medical device supply chain, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology forecasting. The study examines the demand for cardiovascular medical solutions in hospitals, cardiac care centers, catheterization laboratories, and outpatient surgical facilities in France.
Highly Competitive Environment Analysis
In-depth analysis of key cardiovascular device manufacturers, interventional cardiology innovations, AI-enabled remote monitoring platforms, product launch activities, and collaborations is included in the report. The report also covers healthcare regulatory frameworks, medical technology research and development analysis, hospital clinical infrastructure, and new opportunities available in the France Cardiovascular Devices Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Cardiovascular Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Cardiovascular Devices Market
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Edwards Lifesciences Corporation
- Biotronik SE & Co. KG
- Terumo Corporation
- MicroPort Scientific Corporation
- Getinge AB
- LivaNova PLC
- Becton, Dickinson and Company (BD)
Recent Developments:
- In November 2025, Medtronic plc entered into a strategic partnership with a leading French hospital network to deploy AI-powered continuous cardiac rhythm monitoring networks across interventional cardiology departments.
- In May 2025, Boston Scientific Corporation launched its next-generation transcatheter aortic valve implantation system designed for high-precision structural heart repairs and complex interventional procedures.
Market Segmentation:
France Cardiovascular Devices Market, By Product Type
- Structural Heart Devices
- Cardiac Rhythm Management (CRM) Devices
- Electrophysiology Devices
- Interventional Cardiology Catheters & Stents
- Hemodynamic & Vascular Monitoring Systems
France Cardiovascular Devices Market, By Technology
- AI-Based Cardiac Diagnostic Platforms
- Transcatheter Valve Repair & Replacement Technologies
- Wireless Remote Pacemaker Monitoring Systems
- 3D Electrophysiology Mapping Technologies
- Minimally Invasive Endovascular Surgical Systems
France Cardiovascular Devices Market, By Application
- Coronary Artery Disease Management
- Heart Failure & Arrhythmia Treatment
- Structural Heart & Valve Repair
- Vascular Disease & Thrombosis Interventions
- Pediatric & Adult Cardiac Care
Expert Views:
The France cardiovascular devices market will experience growth owing to the growing usage of intelligent diagnostic solutions, medical device innovations, and high demand for interventional cardiology systems. The combination of artificial intelligence-driven cardiac monitoring solutions, minimally invasive surgical technology, and advanced structural heart platforms will enhance clinical effectiveness and drive demand in hospital surgical suites, specialized catheterization labs, outpatient cardiac clinics, and cardiovascular healthcare management sectors.
Author: Govind and Krishna By Decisions Advisors and Consulting